Related Experiment Videos
ACR Appropriateness Criteria ® spinal bone metastases
1, Simon Shek-Man Lo, Stephen T Lutz
1University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA. Simon.Lo@UHhospitals.org
Journal of Palliative Medicine
|November 22, 2012
Summary
Spinal bone metastases require individualized treatment plans considering tumor factors and patient status. Further research is needed to optimize combined therapies for better outcomes in managing spinal metastases.
Area of Science:
- Oncology
- Radiology
- Neurosurgery
Background:
- Spinal bone metastases are common and can cause significant morbidity, including pain, fracture, and neurological deficits.
- Treatment decisions for spinal metastases are complex, influenced by histology, disease extent, and patient's neurological and overall status.
Purpose of the Study:
- To review current treatment strategies for spinal bone metastases.
- To highlight the need for further research into combined and novel therapeutic approaches.
- To emphasize the role of evidence-based guidelines in clinical decision-making.
Main Methods:
- Review of current literature on spinal bone metastases management.
- Discussion of treatment considerations including external beam radiation therapy (EBRT) and surgery.
- Reference to the American College of Radiology Appropriateness Criteria and their development process.
Main Results:
- Treatment is tailored to individual patient and disease characteristics.
- External beam radiation therapy (EBRT) risk-benefit must be carefully weighed.
- Stereotactic body radiation therapy (SBRT) shows emerging roles, requiring further validation.
- Systemic therapies (chemotherapy, hormonal therapy, osteoclast inhibitors, radiopharmaceuticals) combined with localized treatments warrant investigation.
Conclusions:
- Individualized treatment is crucial for spinal bone metastases.
- Further research is essential to explore optimal sequencing and combinations of therapies.
- Evidence-based guidelines support appropriate clinical decision-making for spinal metastases.